Skip to main content
. Author manuscript; available in PMC: 2017 Jan 1.
Published in final edited form as: Cancer Res. 2015 Nov 5;76(1):139–149. doi: 10.1158/0008-5472.CAN-15-1286

Figure 4. αCT1 sensitizes GBM cells to TMZ.

Figure 4

(A) αCT1 peptide is composed of an antennapedia cell internalization domain and 9 amino acids at the CT of Cx43 (i.e., rprpddlei). Viability of SF295 (B), U87MG, (C), VTC-003 (D), LN229 (E), U251 (F), VTC-037 (G), and VTC-005 (H) cells treated with αCT1 and/or TMZ for 1–2 weeks. Error bar depicts standard deviation from experiments performed in triplicate. * p<0.05.